DXCM - NASDAQ
DexCom, Inc.
$72.77
-0.93%DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
At a Glance
Live SnapshotDexCom, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Cash Flow Quality Insight
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
DexCom, Inc. Cash Flow Statement
DXCM • NASDAQ
| DexCom, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
836.3M | 576.2M | 541.5M | 341.2M | 154.7M | 493.6M | 101.1M | -127.1M | -50.2M | -65.6M | -57.6M | -22.4M | -29.8M | -54.5M | -44.7M | -55.2M | -53.5M | -55.2M | -45.9M | -46.6M | |
251.8M | 217.7M | 186M | 155.9M | 102M | 67.1M | 48.7M | 29.1M | 16.1M | 15M | 10.8M | 8.4M | 7M | 6.6M | 3.8M | 2.4M | 2.4M | 3.6M | 3.3M | 2.7M | |
182.2M | -43.8M | -55M | -21.6M | -4.9M | -277.3M | 4.2M | -80.1M | 0.0 | 1.3M | 300K | 300K | 300K | -1.3M | 32.2M | -814K | -8.1M | -7.7M | -6.1M | -5.9B | |
159.6M | 170.4M | 150.8M | 126.5M | 113.4M | 119.4M | 102.7M | 101.9M | 106.2M | 110.8M | 82.7M | 50M | 24.6M | 18.4M | 13.5M | 9.4M | 8.4M | 7.7M | 6.1M | 5.9B | |
-92.6M | -39.8M | -78M | 39.8M | 209.3M | 93.6M | 51.7M | 240.3M | 17.3M | 1M | 37.2M | 100K | 3.1M | 1.6M | -31.2M | 11.2M | 13.8M | 8M | 5.6M | 5.5M | |
(94.4M) | (198M) | (212.3M) | (114.2M) | (16.8M) | (3.6M) | (4.8M) | (2.3M) | (1.4M) | (100K) | (100K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
103.4M | 108.8M | 3.2M | 27.7M | -132M | -20.8M | 6.1M | -40.9M | 2.6M | -6.3M | -24.4M | -12.8M | -2.8M | -3.9M | -3.6M | -9.8M | -2.2M | 6.1M | 3.7M | -5.3M | |
1.4B | 989.5M | 748.5M | 669.5M | 442.5M | 475.6M | 314.5M | 123.2M | 92M | 56.2M | 49M | 23.6M | 2.4M | -33.1M | -30.1M | -42.7M | -39.4M | -37.5M | -33.2M | -43.7M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-363.5M | -358.8M | -236.6M | -364.8M | -389.2M | -199M | -180M | -67.1M | -66M | -55.7M | -33.3M | -16.2M | -7.9M | -9.5M | -8M | -6.9M | -3M | -2.5M | -3.4M | -3.4M | |
(0.0) | (0.0) | (0.0) | -3.9M | -30.2M | (0.0) | (835.2M) | -11.3M | (0.0) | (300K) | -500K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-1.3B | -2.7B | -3.2B | -2.3B | -2.5B | -3.1B | -2B | -453.5M | -171.8M | -39.2M | -45.2M | -13.8M | -16.3M | -66.4M | -102.7M | -73.4M | -65.3M | -37M | -76.9M | -61.7M | |
2.2B | 2.8B | 2.9B | 2.1B | 2.7B | 2.3B | 1.2B | 392.1M | 93.4M | 38.7M | 27.5M | 13.2M | 45.1M | 104.3M | 64.3M | 54.7M | 53.9M | 63.8M | 71.9M | 38.5M | |
600K | -15.5M | -17.6M | -14.3M | 10.1M | -11.3M | -835.2M | -61.4M | -78.4M | -500K | -17.7M | -600K | 28.8M | 37.9M | 4K | 6K | 302K | 0.0 | 0.0 | 0.0 | |
(536M) | -207.5M | -507.2M | -521.5M | -216.1M | -1B | -1B | -139.8M | -144.4M | -55.9M | -51.5M | -16.8M | (20.9M) | (28.4M) | -46.4M | -25.6M | -14.1M | (24.3M) | -8.4M | -26.6M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-471.9M | -721.8M | -662.1M | -535.2M | 20.3M | 15.3M | 11.9M | -89.2M | 10.1M | 10.4M | 19.1M | 24M | 12M | 3.6M | 74.7M | 70.5M | 46.3M | 1.8M | -1.8M | 48.2M | |
-1.2B | 0.0 | 443.3M | 0.0 | 0.0 | 906.2M | 0.0 | 836.6M | 389M | -2.3M | -2.3M | -2.2M | -200K | 6.6M | -500K | -900K | -1.9M | 950K | 48.4M | 3M | |
-500M | -750M | -688.7M | -557.7M | (0.0) | (0.0) | (0.0) | -100M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -2.7M | (0.0) | |
-7M | -13M | -99.8M | -17.3M | -9.9M | -9.4M | -1.2M | -37M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -16K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-1.7B | -734.8M | -318.6M | -552.5M | 10.4M | 912.1M | 10.7M | 710.4M | 399.1M | 8.1M | 16.8M | 21.8M | 11.8M | 10.2M | 74.2M | 69.6M | 44.4M | 2.7M | 46.6M | 51.2M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
21.5M | -7.4M | 1.5M | -5.8M | -1.4M | 2.1M | -700K | 1.8M | 300K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23K | -48K | -9K | 0.0 | 0.0 | 0.0 | |
311.8M | 39.8M | -75.8M | -410.3M | 235.4M | 371.8M | -690.7M | 695.6M | 347M | 8.4M | 14.3M | 28.6M | 35.1M | 5.5M | -2.3M | 1.3M | -9.1M | -10.4M | 4.9M | -19.1M | |
607.3M | 567.5M | 643.3M | 1.1B | 818.2M | 446.4M | 1.1B | 441.5M | 94.5M | 86.1M | 71.8M | 43.2M | 8.1M | 2.6M | 4.9M | 3.6M | 12.7M | 23.1M | 18.2M | 37.2M | |
919.1M | 607.3M | 567.5M | 643.3M | 1.1B | 818.2M | 446.4M | 1.1B | 441.5M | 94.5M | 86.1M | 71.8M | 43.2M | 8.1M | 2.6M | 4.9M | 3.6M | 12.7M | 23.1M | 18.2M | |
1.1B | 630.7M | 511.9M | 304.7M | 53.3M | 276.6M | 134.5M | 56.1M | 26M | 500K | 15.7M | 7.4M | -5.5M | -42.6M | -38.1M | -49.5M | -42.4M | -39.9M | -36.7M | -47.1M |
SEC Filings
DXCM - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 15, 2026 | May 14, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 15, 2026 | May 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | February 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 12, 2026 | February 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 07, 2026 | 2026 |
Related Guides
Continue your DXCM research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.